| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Aging of mesenchymal stem cell in vitro.
|
BMC Cell Biol
|
2006
|
3.32
|
|
2
|
Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
|
Arch Iran Med
|
2007
|
2.12
|
|
3
|
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling.
|
Blood
|
2013
|
1.68
|
|
4
|
Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
|
Liver Int
|
2013
|
1.64
|
|
5
|
Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis.
|
Pediatr Transplant
|
2015
|
1.39
|
|
6
|
Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study.
|
Iran J Immunol
|
2007
|
1.39
|
|
7
|
Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction.
|
Arch Iran Med
|
2007
|
1.20
|
|
8
|
HLA-matched sibling bone marrow transplantation for β-thalassemia major.
|
Blood
|
2010
|
1.20
|
|
9
|
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
|
Biol Blood Marrow Transplant
|
2013
|
1.07
|
|
10
|
Stem cell therapy in treatment of different diseases.
|
Acta Med Iran
|
2012
|
1.02
|
|
11
|
Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin.
|
World J Gastroenterol
|
2008
|
1.02
|
|
12
|
Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden.
|
Blood Coagul Fibrinolysis
|
2010
|
0.96
|
|
13
|
Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia.
|
Leuk Lymphoma
|
2006
|
0.96
|
|
14
|
Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
|
Transpl Immunol
|
2005
|
0.96
|
|
15
|
Prognostic factors of survival time after hematopoietic stem cell transplant in acute lymphoblastic leukemia patients: Cox proportional hazard versus accelerated failure time models.
|
J Exp Clin Cancer Res
|
2008
|
0.87
|
|
16
|
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
|
Retrovirology
|
2013
|
0.86
|
|
17
|
Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population.
|
Ann Transplant
|
2007
|
0.86
|
|
18
|
Autologous stem cell transplantation as treatment modality in a patient with relapsed pancreatoblastoma.
|
Pediatr Blood Cancer
|
2010
|
0.85
|
|
19
|
Successful fludarabine-based hematopoietic stem cell transplantation in a pediatric patient with idiopathic CD4+ lymphocytopenia.
|
Pediatr Transplant
|
2013
|
0.85
|
|
20
|
First report of successful stem cell transplantation in a patient with sickle cell hemoglobin D disease.
|
J Pediatr Hematol Oncol
|
2010
|
0.85
|
|
21
|
Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
|
Tumour Biol
|
2011
|
0.84
|
|
22
|
The relationship between body mass index and outcomes in leukemic patients undergoing allogeneic hematopoietic stem cell transplantation.
|
Clin Transplant
|
2011
|
0.84
|
|
23
|
Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
|
Hematol Oncol Stem Cell Ther
|
2011
|
0.84
|
|
24
|
Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.
|
Nutr Cancer
|
2013
|
0.84
|
|
25
|
Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.
|
Exp Hematol
|
2008
|
0.84
|
|
26
|
KIR2DS3 is associated with protection against acute myeloid leukemia.
|
Iran J Immunol
|
2010
|
0.83
|
|
27
|
Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.
|
Urol Oncol
|
2007
|
0.83
|
|
28
|
Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera.
|
Med Oncol
|
2010
|
0.83
|
|
29
|
Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study.
|
Cancer Chemother Pharmacol
|
2013
|
0.82
|
|
30
|
Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation.
|
Mol Cell Endocrinol
|
2011
|
0.82
|
|
31
|
Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
|
Med Oncol
|
2009
|
0.82
|
|
32
|
Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial.
|
Support Care Cancer
|
2013
|
0.82
|
|
33
|
The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience.
|
J Pediatr Hematol Oncol
|
2012
|
0.82
|
|
34
|
Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
|
Ann Hematol
|
2013
|
0.82
|
|
35
|
Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9.
|
Anticancer Drugs
|
2010
|
0.81
|
|
36
|
Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.
|
Hematology
|
2012
|
0.81
|
|
37
|
Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran.
|
Arch Iran Med
|
2011
|
0.81
|
|
38
|
Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.
|
J Cell Biochem
|
2014
|
0.80
|
|
39
|
Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience.
|
J Pediatr Hematol Oncol
|
2013
|
0.80
|
|
40
|
Gluthatione-S-transferase T1-null genotype predisposes adults to acute promyelocytic leukemia; a case-control study.
|
Asian Pac J Cancer Prev
|
2011
|
0.80
|
|
41
|
Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.
|
Neurochem Res
|
2011
|
0.80
|
|
42
|
Development and validation of limited sampling strategies for estimation of cyclosporine area under the concentration-time curve in hematopoietic stem cell transplant patients.
|
Ther Drug Monit
|
2011
|
0.80
|
|
43
|
Interaction of arsenic trioxide As2O3 with DNA and RNA.
|
DNA Cell Biol
|
2005
|
0.80
|
|
44
|
Substance P and calcitonin gene-related neuropeptides as novel growth factors for ex vivo expansion of cord blood CD34(+) hematopoietic stem cells.
|
Growth Factors
|
2010
|
0.80
|
|
45
|
The prevalence of low selenium levels in adult patients undergoing bone marrow transplantation: a brief communication.
|
Nutr Cancer
|
2008
|
0.80
|
|
46
|
Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.
|
Biol Blood Marrow Transplant
|
2011
|
0.80
|
|
47
|
Impact of preexisting diabetes mellitus on transplantation outcomes in hematopoietic stem cell transplantation.
|
Endocr Res
|
2014
|
0.79
|
|
48
|
The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study.
|
Hematol Oncol
|
2011
|
0.79
|
|
49
|
Selenium supplementation in patients undergoing hematopoietic stem cell transplantation: effects on pro-inflammatory cytokines levels.
|
Daru
|
2014
|
0.79
|
|
50
|
Expression of MRP1 gene in acute leukemia.
|
Sao Paulo Med J
|
2008
|
0.79
|
|
51
|
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
|
Hematol Oncol Stem Cell Ther
|
2013
|
0.79
|
|
52
|
Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
|
Hematology
|
2007
|
0.79
|
|
53
|
Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.
|
Exp Clin Transplant
|
2010
|
0.78
|
|
54
|
TGF-Beta codon 25 polymorphism and the risk of graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
|
Iran J Allergy Asthma Immunol
|
2010
|
0.78
|
|
55
|
Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.
|
Neurochem Res
|
2012
|
0.78
|
|
56
|
BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.
|
Anticancer Agents Med Chem
|
2013
|
0.78
|
|
57
|
Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
|
Leuk Lymphoma
|
2012
|
0.78
|
|
58
|
Matched related donor hematopoietic stem cell transplantation results in a long-term follow-up of a pediatric acquired severe aplastic anemia subset: A stem cell source perspective.
|
Pediatr Transplant
|
2015
|
0.78
|
|
59
|
Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
|
Eur J Haematol
|
2014
|
0.78
|
|
60
|
Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
|
Mol Cell Endocrinol
|
2013
|
0.77
|
|
61
|
Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients.
|
Hematol Oncol Stem Cell Ther
|
2011
|
0.77
|
|
62
|
Hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen in pediatric patients with Griscelli syndrome type 2.
|
Pediatr Transplant
|
2013
|
0.77
|
|
63
|
Data mining in bone marrow transplant records to identify patients with high odds of survival.
|
IEEE J Biomed Health Inform
|
2014
|
0.77
|
|
64
|
Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a leukocyte adhesion deficiency type I patient.
|
Pediatr Transplant
|
2011
|
0.77
|
|
65
|
Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
|
Arch Iran Med
|
2006
|
0.77
|
|
66
|
Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.
|
Arch Iran Med
|
2011
|
0.76
|
|
67
|
Serum electrolyte changes at engraftment time in patients undergoing allogeneichematopoietic stem cell transplantation.
|
Ann Transplant
|
2009
|
0.76
|
|
68
|
Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO).
|
Transfus Apher Sci
|
2010
|
0.76
|
|
69
|
Use of Novoseven for arsenic trioxide-induced bleeding in PML.
|
Am J Hematol
|
2006
|
0.76
|
|
70
|
The treatment of children suffering from chronic myelogenous leukemia: a comparison of the result of treatment with imatinib mesylate and allogeneic hematopoietic stem cell transplantation.
|
Pediatr Transplant
|
2013
|
0.76
|
|
71
|
Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia.
|
Cancer Chemother Pharmacol
|
2014
|
0.76
|
|
72
|
Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation.
|
Haematologica
|
2013
|
0.76
|
|
73
|
Communication of substance P, calcitonin-gene-related neuropeptides and chemokine receptor 4 (CXCR4) in cord blood hematopoietic stem cells.
|
Neuropeptides
|
2010
|
0.76
|
|
74
|
Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study.
|
Pediatr Hematol Oncol
|
2010
|
0.75
|
|
75
|
Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.
|
Iran Biomed J
|
2012
|
0.75
|
|
76
|
Effects of neuropeptide substance P on the expression of adhesion molecules in cord blood hematopoietic stem cells.
|
Ann Hematol
|
2010
|
0.75
|
|
77
|
Bronchiolitis obliterans following hematopoietic stem cell transplantation.
|
Hematol Oncol Stem Cell Ther
|
2010
|
0.75
|
|
78
|
Osteopontin b and c isoforms: Molecular Candidates Associated with Leukemic Stem Cell Chemoresistance in Acute Myeloid Leukemia
|
Asian Pac J Cancer Prev
|
2017
|
0.75
|
|
79
|
Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stell Cell Compartments in Response to Curcumin and Daunorubicin
|
Asian Pac J Cancer Prev
|
2017
|
0.75
|
|
80
|
AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy.
|
Tumour Biol
|
2014
|
0.75
|
|
81
|
Comparison of bone mineral density changes in pediatric thalassemic patients with and without hematopoietic stem cell transplant.
|
Exp Clin Transplant
|
2014
|
0.75
|
|
82
|
Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East.
|
Ann Hematol
|
2014
|
0.75
|
|
83
|
Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.
|
Mol Biol Rep
|
2014
|
0.75
|
|
84
|
Efficacy of hepatic T2* MRI values and serum ferritin concentration in predicting thalassemia major classification for hematopoietic stem cell transplantation.
|
Pediatr Transplant
|
2015
|
0.75
|
|
85
|
Gibbon ape leukemia virus transduction of peripheral blood CD34+-derived dendritic cells.
|
Hematol Oncol Stem Cell Ther
|
2010
|
0.75
|
|
86
|
Long-term follow-up of children treated with daclizumab for steroid-refractory gastrointestinal GvHD in a prospective study.
|
Pediatr Transplant
|
2012
|
0.75
|
|
87
|
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
|
J Natl Compr Canc Netw
|
2010
|
0.75
|
|
88
|
Role of substance P (SP) and calcitonin gene-related peptide (CGRP) in gibbon-ape-leukemia virus (GALV) transduction of CD34+ cells.
|
Neuropeptides
|
2010
|
0.75
|
|
89
|
Reactive oxygen species generation and increase in mitochondrial copy number: new insight into the potential mechanism of cytotoxicity induced by aurora kinase inhibitor, AZD1152-HQPA.
|
Anticancer Drugs
|
2017
|
0.75
|
|
90
|
Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells
|
Asian Pac J Cancer Prev
|
2017
|
0.75
|
|
91
|
OPN b and c Isoforms Doubtless Veto Anti-angiogenesis Effects of Curcumin in Combination with Conventional AML Regiment
|
Asian Pac J Cancer Prev
|
2017
|
0.75
|
|
92
|
Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism.
|
Asian Pac J Cancer Prev
|
2016
|
0.75
|
|
93
|
Calcitriol for Oral Mucositis Prevention in Patients With Fanconi Anemia Undergoing Hematopoietic SCT: A Double-Blind, Randomized, Placebo-Controlled Trial.
|
Am J Ther
|
2015
|
0.75
|
|
94
|
Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma.
|
Anticancer Agents Med Chem
|
2015
|
0.75
|
|
95
|
The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study.
|
Pediatr Transplant
|
2014
|
0.75
|
|
96
|
Changes of bone density in pediatric patients with β-thalassemia major after allogenic hematopoietic stem cell transplantation.
|
Arch Iran Med
|
2013
|
0.75
|
|
97
|
Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.
|
Med Oncol
|
2011
|
0.75
|
|
98
|
Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran.
|
Haematologica
|
2003
|
0.75
|
|
99
|
FLT3 Gene Mutation Profile and Prognosis in Adult Acute Myeloid Leukemia.
|
Clin Lab
|
2016
|
0.75
|
|
100
|
Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines
|
Asian Pac J Cancer Prev
|
2017
|
0.75
|
|
101
|
Differential sensitivity of p44/p42-MAPK- and PI3K/Akt-targeted neuroblastoma subtypes to arsenic trioxide.
|
Neurochem Int
|
2013
|
0.75
|